Three-year follow-up for coronary disease and atrial fibrillation
Part of Heart & circulation clinical trials.
This is a follow-up study checking on people who were in the pCAD-POAF trial for 3 years after they joined. It looks at what happens over time for people with both coronary artery disease and atrial fibrillation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have already taken part in the pCAD-POAF trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry study follows people with atrial fibrillation to learn which risk factors are linked to stroke or blood clots traveling through the body. Your information helps improve how doctors predict risk and choose prevention strategies.
This trial is looking at what happens after a heart procedure called catheter ablation for atrial fibrillation (an irregular heartbeat). It mainly collects follow-up outcomes to better understand recovery and results for patients.
This trial follows people with atrial fibrillation to see how long-term blood-thinning treatment affects outcomes over time. It may help determine which long-term approach best lowers stroke and clot risks for patients like you.
This registry collects information on people with atrial fibrillation to understand how different treatments affect their health and quality of life over time.
This study follows people after a procedure called catheter ablation to treat atrial fibrillation (an irregular heart rhythm). It aims to learn which factors help predict outcomes, so future care can be better tailored.
This study tests a new catheter to treat persistent atrial fibrillation (a type of irregular heartbeat lasting more than 7 days but less than a year). It aims to isolate the pulmonary veins and superior vena cava to restore normal rhythm. Some participants may also receive a left atrial appendage occlusion device if needed.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.